Clinical trial

A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty…

NCT00344721 · University of Texas Southwestern Medical Center, Other · Completed

Key facts

NCT number NCT00344721
Title A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Official title A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Lead sponsor University of Texas Southwestern Medical Center, Other
Collaborators Advanced Vision Research Industry
Status Completed
Study type Interventional
Conditions Dry Eye Syndrome
Intervention type Dietary Supplement
Interventions Omega-3 fatty acid supplement, Placebo
Enrollment 42
Start date Sep 1, 2004
Primary completion Oct 1, 2008
Completion Oct 1, 2008
First posted Jun 27, 2006
Last update posted May 14, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies